Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure
暂无分享,去创建一个
P. Calabresi | P. Albert | J. Frank | Joseph Frank | H. McFarland | L. Stone | H. Maloni | C. Bash | P. Albert
[1] M Filippi,et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS , 1996, Neurology.
[2] H. McFarland,et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions , 1993, Annals of neurology.
[3] J. Parisi,et al. Neurological involvement in Wegener's granulomatosis: An analysis of 324 consecutive patients at the Mayo Clinic , 1993, Annals of neurology.
[4] M. Fukushima. [Principles of cancer chemotherapy]. , 1990, Nihon Seikeigeka Gakkai zasshi.
[5] J. Ebersole,et al. An evaluation of ambulatory, cassette EEG monitoring , 1983, Neurology.